SCAM Faster in reverse than in forward....
Just to be unclear for those foolish enough to throw down with the likes of the CDEX truth sayers..
First it was ready for sale, with pending contracts, in final form....able to do multi component medications, non-invasive, see through bags, syringes and vials, hurry, hurry step right up.
Then it was , in the near future, pull some out of the bag, vial, and place in a known syringe. We expect, blah , blah ,blah.
Don't forget in 2011 "full commercial production" And of course it's sorta patented we think...The ASHP in December 2013 will really clear it up. No formal announcement from CDEX, just some words from a long time, Loch/cdex stock holder, flush with new pride in the new CDEX stock. Third time is the charm or maybe fourth time who knows.
TUCSON, AZ--(Marketwire - 12/07/10) - CDEX Inc.
Company will exhibit its proprietary ValiMed G4 multi-component medication and narcotic detection system, at the 45th Annual Midyear ASHP
The G4 identifies the drug, the dose, the diluents, and is the first to feature multi-component compound detection.
The G4 will have an enhanced software platform for improved accuracy and reliability, while able to perform non-invasive measures of compounds directly through IV bags, syringes and vials,
CDEX PR 12/6/2011
today demonstrated its recently launched ValiMed™ G4 multi-component medication and narcotic detection system at the 46th Annual Midyear ASHP
With the recent launch and commercial production of our ValiMed™ G4 system, we are excited to showcase the system at the ASHP Midyear conference, where a national and international audience of industry professionals will witness the power of our technology. We are the first to commercialize an affordable advanced measuring system
The patented detection process identifies drug strengths and volume-by-weight in real-time, validating proper dose, diluents and concentration of high-risk compounded medications and treatment solutions.
TUCSON, AZ--(Marketwire - Nov 28, 2012) - CDEX Inc. (OTCQB: CDEX),
today announced the company will participate at the 47th Annual Midyear ASHP Clinical Meeting and Exhibition to demonstrate the ValiMed™ G4 medication safety, and narcotic detection system.
The patented & patent pending detection process identifies drug strengths in real-time, validating proper dose / concentration of high-risk compounded medications and treatment solutions.
10-Q 14-Jun-2013
The VG4 system uses a patented detection process providing a real time (within seconds), quantitative (strength/concentration) as well as qualitative (identification of an unknown) analysis of high-risk single component compounded medications and treatment solutions.
In the near future, we expect the VG4 product line to address multi component compounded mixtures, such as total parenteral nutrition.
We expect to add oncology drugs to our formulary in 2013 as well. One of the most significant improvements with the VG4 is the capability of analyzing through most containers that are currently being used in pharmaceutical settings.
AI
